Own Medicine for Vision Loss: Inhibitor of Angiogenesis Found
by TSRI Biologists
A potentially potent inhibitor of angiogenesis, the process
whereby new blood vessels are formed from existing ones, can
be found in one of the very molecules involved in the same
process. This finding, made by two scientists from TSRI, may
lead to new therapies, as abnormal angiogenesis is the leading
cause of vision loss in the United States.
Affinity Group Brings Together Basic Researchers and Physicians
TSRI's Cancer Affinity Group promotes intellectual enrichment,
scientific discussion, and exchange of ideas among the region's
scientists and clinicians.
Trustee Inducted into the National Inventors Hall of Fame
Herb Boyer, a member of The Scripps Research Institute (TSRI)
Board of Trustees, was recently inducted into the National
Inventors Hall of Fame, which celebrates the creative and
entrepreneurial spirit of great inventors.
Investigator Dennis Burton at TSRI studies a number of viruses,
including the Ebola virus. "The virus is intriguing because
it acts so quickly," Burton says. "It kills people in two
weeks or less."